After 5 days of RA treatment, ZRF1 levels were found to be decreased 3–4 times in the RA-treated SH-SY5Y and SK-N-BE(2) neuroblastoma cell lines, as compared with vehicle-treated cells (Figure 4a). Here, DNAJC2 is linked to neuroblastoma.